4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-038215
General Counsel and Secretary sold 3,966 shares at an average $42.67 ($169,242)
- General Counsel and Secretary acquired 7,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…